Literature DB >> 4049533

Mycobacterium malmoense in the north-east of England.

M J Connolly, J G Magee, D J Hendrick, P A Jenkins.   

Abstract

We report a 6 year experience (1979-1984) of isolating Mycobacterium malmoense in the north-east of England. Eleven subjects were involved of whom 10 had active infection--9 pulmonary, one cervical adenitis. The 11 new isolates represent 0.7% of all new mycobacterial isolates during this period and 10% of new non-tuberculous isolates. In all but 2 cases there was pre-existing pulmonary disease and/or a recognised predisposing factor to mycobacterial infection. The organisms were generally insensitive to isoniazid but sensitive to both rifampicin and ethionamide. The results of chemotherapy are described.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4049533     DOI: 10.1016/0041-3879(85)90039-x

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


  8 in total

1.  Mycobacterium malmoense in Italy: the modern Norman invasion?

Authors:  E Tortoli; C Piersimoni; A Bartoloni; C Burrini; A P Callegaro; G Caroli; D Colombrita; A Goglio; A Mantella; C P Tosi; M T Simonetti
Journal:  Eur J Epidemiol       Date:  1997-04       Impact factor: 8.082

Review 2.  Agents of newly recognized or infrequently encountered mycobacterial diseases.

Authors:  L G Wayne; H A Sramek
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

Review 3.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

4.  Mycobacterium malmoense and carcinoma of lung.

Authors:  R E Meigh; A G Arnold
Journal:  Thorax       Date:  1994-08       Impact factor: 9.139

Review 5.  Pulmonary infections caused by less frequently encountered slow-growing environmental mycobacteria.

Authors:  S E Hoffner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

6.  Definition of the surface antigens of Mycobacterium malmoense and use in studying the etiology of a form of mycobacteriosis.

Authors:  M McNeil; A Y Tsang; J K McClatchy; C Stewart; I Jardine; P J Brennan
Journal:  J Bacteriol       Date:  1987-07       Impact factor: 3.490

7.  Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinations.

Authors:  S E Hoffner; U Hjelm; G Källenius
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

8.  Septic cutaneous lesions caused by Mycobacterium malmoense in a patient with hairy cell leukemia.

Authors:  B Castor; I Juhlin; B Henriques
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-02       Impact factor: 3.267

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.